Here's Why You Should Add Cerner (CERN) to Your PortfolioHomeMailNewsFinanceSportsEntertainmentSearchMobileMoreYahooSearchNo matching results for ''Tip: Try a valid symbol or a specific company name for relevant resultsSign inMailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets open in 9 hrs 16 minsS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Here's Why You Should Add Cerner (CERN) to Your PortfolioZacks Equity ResearchZacksJanuary 10, 2020ReblogShareTweetShareCerner Corporation CERN is likely to gain from a series of recent developments and a strong view for the fourth quarter of 2019.Shares of this company have rallied 37.9% compared with the industry’s 18% rise in a year’s time. The current level also compares favorably with the S&P 500 index’s 27.6% rise over the same time frame.This $23.07-billion healthcare IT company currently has a Zacks Rank #2 (Buy). Cerner’s earnings are expected to grow 10.7% over the next five years. Also, the company has a trailing four-quarter positive earnings surprise of 1.2%, on average.The stock also has a Growth Score of B. Our research shows that stocks with a Growth Score of A or B, when combined with a Zacks Rank #1 (Strong Buy) or 2, are better picks than most.Let’s take a closer look at the factors that are working in favor of the company right now.View photosSlew of Developments & GuidanceIn recent times, Cerner has seen some positive developments.Last month, the company announced plans to assist clients to further lower re-admission rates for patients, thereby reducing healthcare costs. This will help cut the amount of time physicians spend documenting patient visits. Additionally, the company announced an investment and partnership with i2i Systems in recent times.Moreover, Vively Health, a risk-based provider delivering home-based primary care to the ost ulnerable atients in the United States, announced a five-year collaboration with Cerner. Per management, the goal is to improve care delivery and health outcomes for patients with multiple chronic conditions.In recent times, Cerner also collaborated with Uber UBER to reduce transportation barriers that can lead to delayed care, poor management of chronic conditions and declining health outcomes for patients.Reflective of these, Cerner issued a strong outlook for the fourth quarter.The company expects revenues between $1.41 billion and $1.46 billion. The mid-point of this range indicates growth of 5% from the prior-year quarter.Cerner Corporation Price and ConsensusView photosCerner Corporation Price and ConsensusMoreCerner Corporation price-consensus-chart | Cerner Corporation QuoteAdjusted earnings per share (EPS) are anticipated to range between 73 cents and 75 cents. The mid-point of this range is 17% higher than that reported in third-quarter 2018. This will bring full-year 2019 adjusted EPS to $2.67, indicating growth of 9% over 2018 levels.Bookings revenues for fourth-quarter 2019 are estimated between $1.45 billion and $1.65 billion. The mid-point of this range indicates a decline of 21% from the prior-year quarter.Which Way Are Estimates Headed?For 2019, the Zacks Consensus Estimate for revenues is pegged at $5.69 billion. For adjusted EPS, the same stands at $2.67 per share, suggesting an upside of 9% from the year-ago reported figure.Other Stocks to ConsiderOther top-ranked stocks from the broader medical space are DexCom DXCM and HealthEquity HQY. While HealthEquity sports a Zacks Rank #1, DexCom carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.Story continuesDexCom’s fourth-quarter earnings growth rate is projected at 31.5%.HealthEquity’s long-term earnings growth rate is 25%.5 Stocks Set to DoubleEach was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cerner Corporation (CERN) : Free Stock Analysis Report DexCom, Inc. (DXCM) : Free Stock Analysis Report HealthEquity, Inc. (HQY) : Free Stock Analysis Report Uber Technologies, Inc. (UBER) : Free Stock Analysis Report To read this article on Zacks.com click here.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoCrocs CEO explains its major turnaroundYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoMincor Resources (ASX:MCR) Is In A Strong Position To Grow Its BusinessSimply Wall St.What the GM strike means for the U.S. economyYahoo FinanceWhy negative interest rates are 'seriously dangerous': strategistYahoo FinanceAurora Cannabis tumbles after double downgradeYahoo Finance VideoCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoEiffage SA Annual Results Just Came Out: Here's What Analysts Are Forecasting For Next YearSimply Wall St.Loan growth will be a 'critical factor' in upcoming bank earnings: AnalystYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceU.S. airlines suspend flights over coronavirus fearsYahoo Finance VideoBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo Finance